Lizzul Paul F. (CIK 1711462) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-09). Recent activity: Buy ANAB (8,525 shares), Sell ANAB (3,650 shares), Buy ANAB (6,145 shares), Sell ANAB (2,235 shares), Buy ANAB (10,555 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-09 | ANAPTYSBIO, INC (ANAB) | Chief Medical Officer | Buy | 8,525 | $0 |
| 2026-01-09 | ANAPTYSBIO, INC (ANAB) | Chief Medical Officer | Sell | 3,650 | $163,192 |
| 2026-01-08 | ANAPTYSBIO, INC (ANAB) | Chief Medical Officer | Buy | 6,145 | $0 |
| 2026-01-08 | ANAPTYSBIO, INC (ANAB) | Chief Medical Officer | Sell | 2,235 | $100,821 |
| 2026-01-06 | ANAPTYSBIO, INC (ANAB) | Chief Medical Officer | Buy | 10,555 | $0 |
| 2026-01-06 | ANAPTYSBIO, INC (ANAB) | Chief Medical Officer | Sell | 4,219 | $182,514 |
| 2025-12-23 | ANAPTYSBIO, INC (ANAB) | Chief Medical Officer | Buy | 1,500 | $27,750 |
| 2025-12-23 | ANAPTYSBIO, INC (ANAB) | Chief Medical Officer | Sell | 1,500 | $75,000 |
Source: SEC Form 4 filings · as of 2026-01-09